By Mike "Mish" Shedlock An interesting article came my way from UBS analyst Julien Garran on the driver for gold. I do not …
Are we watching a replay of the last financial crisis? Over the past six months, the price of oil has collapsed, the U.
Written by Scott Matusow. Sometimes in biotech, things do not go as expected.
Canaccord Genuity analyst Joe Mazumdar came out with a few insights on Midway Gold Corp (USA) (NYSE MKT:MDW), after the company announced the first gold pour (100 oz) from their …
Since Cypress Semiconductor Corporation (NASDAQ:CY) completed the acquisition of Spansion Inc., Needham analyst Rajvindra Gill reiterated a Buy rating on CY on March 31 with a price target of …
GW Pharmaceuticals PLC- ADR (Nasdaq:GWPH) (AIM:GWP), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, …
Maxim Group's healthcare analyst Jason Kolbert has high hopes for Gilead Sciences, Inc. (NASDAQ:GILD), reiterating a Buy recommendation on the stock with a 12-month price target of …
It’s an exciting week ahead for the biotech and technology sectors as three big players are scheduled to announce their quarterly financial results. …
Mobile company turned software company BlackBerry Ltd (NASDAQ: BBRY) announced its fourth quarter 2015 financial results on Friday, March 27th, revealing a surprise profit. …
Canadian Solar (NASDAQ:CSIQ), one of the world’s largest solar power companies, today announced the sale of the 10 MW AC GoldLight (“GoldLight”) solar …
